$SHOO
STEVEN MADDEN, LTD. Stock $shoo

$shoo Overview Financials Valuation SEC Filings Company Website

2021 Q1 Form 10-Q Financial Statement

#000162828021009267 Filed on May 06, 2021

Income Statement

Concept	2021 Q1	2020 Q1
Revenue	$361.0M	$359.2M
YoY Change	0.52%	-13.62%
Cost Of Revenue	$221.9M	$225.7M
YoY Change	-1.68%	-11.12%
Gross Profit	$139.1M	$133.5M
YoY Change	4.23%	-17.54%
Gross Profit Margin	38.53%	37.16%
Selling, General & Admin	$5.500M	$5.700M
YoY Change	-3.51%	0.0%
% of Gross Profit	3.95%	4.27%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$4.028M	$4.996M
YoY Change	-19.38%	-6.62%
% of Gross Profit	2.9%	3.74%
Operating Expenses	$110.4M	$121.4M
YoY Change	-9.0%	3.57%
Operating Profit	$28.04M	-$26.25M
YoY Change	-206.84%	-158.77%
Interest Expense	$0.00	$1.000M
YoY Change	-100.0%	-16.67%
% of Operating Profit	0.0%
Other Income/Expense, Net
YoY Change
Pretax Income	$28.01M	-$25.20M
YoY Change	-211.13%	-154.96%
Income Tax	$5.676M	-$7.401M
% Of Pretax Income	20.27%
Net Earnings	$22.33M	-$17.45M
YoY Change	-227.96%	-150.55%
Net Earnings / Revenue	6.19%	-4.86%
Basic Earnings Per Share	$0.27	-$0.22
Diluted Earnings Per Share	$0.26	-$0.22
COMMON SHARES
Basic Shares Outstanding	79.04M shares	78.88M shares
Diluted Shares Outstanding	81.89M shares	78.88M shares

Balance Sheet

Concept	2021 Q1	2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$273.0M	$245.4M
YoY Change	11.25%	10.74%
Cash & Equivalents	$233.2M	$211.1M
Short-Term Investments	$39.80M	$34.30M
Other Short-Term Assets	$35.10M	$31.60M
YoY Change	11.08%	11.66%
Inventory	$106.6M	$102.3M
Prepaid Expenses
Receivables	$9.730M	$261.6M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$734.5M	$640.8M
YoY Change	14.63%	-3.07%
LONG-TERM ASSETS
Property, Plant & Equipment	$40.46M	$52.21M
YoY Change	-22.5%	-17.99%
Goodwill	$168.0M	$165.9M
YoY Change	1.28%	11.8%
Intangibles	$186.0M	$254.8M
YoY Change	-27.03%	7.11%
Long-Term Investments
YoY Change
Other Assets	$5.216M	$2.982M
YoY Change	74.92%	49.47%
Total Long-Term Assets	$434.4M	$505.1M
YoY Change	-14.0%	-7.94%
TOTAL ASSETS
Total Short-Term Assets	$734.5M	$640.8M
Total Long-Term Assets	$434.4M	$505.1M
Total Assets	$1.169B	$1.146B
YoY Change	2.01%	-5.28%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$99.01M	$76.28M
YoY Change	29.79%	21.93%
Accrued Expenses	$120.3M	$87.70M
YoY Change	37.12%	-12.2%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$29.10M
YoY Change	-100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$256.5M	$232.7M
YoY Change	10.22%	14.16%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$108.9M	$135.6M
YoY Change	-19.69%	-20.84%
Total Long-Term Liabilities	$108.9M	$135.6M
YoY Change	-19.69%	-20.84%
TOTAL LIABILITIES
Total Short-Term Liabilities	$256.5M	$232.7M
Total Long-Term Liabilities	$108.9M	$135.6M
Total Liabilities	$368.2M	$372.3M
YoY Change	-1.1%	-1.83%
SHAREHOLDERS EQUITY
Retained Earnings	$1.288B	$1.280B
YoY Change	0.61%	3.27%
Common Stock	$8.000K	$6.000K
YoY Change	33.33%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$957.8M	$934.8M
YoY Change	2.46%	-213.85%
Treasury Stock Shares	50.79M shares	50.11M shares
Shareholders Equity	$787.5M	$761.2M
YoY Change
Total Liabilities & Shareholders Equity	$1.169B	$1.146B
YoY Change	2.01%	-5.28%

Cashflow Statement

Concept	2021 Q1	2020 Q1
OPERATING ACTIVITIES
Net Income	$22.33M	-$17.45M
YoY Change	-227.96%	-150.55%
Depreciation, Depletion And Amortization	$4.028M	$4.996M
YoY Change	-19.38%	-6.62%
Cash From Operating Activities	$5.042M	-$39.61M
YoY Change	-112.73%	151.42%
INVESTING ACTIVITIES
Capital Expenditures	$1.598M	$3.301M
YoY Change	-51.59%	-2.88%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$3.100M
YoY Change	-100.0%	-50.0%
Cash From Investing Activities	-$1.616M	-$227.0K
YoY Change	611.89%	-108.21%
FINANCING ACTIVITIES
Cash Dividend Paid	$12.43M	$12.46M
YoY Change	-0.27%	3.46%
Common Stock Issuance & Retirement, Net	$5.558M	$29.14M
YoY Change	-80.93%	-269.87%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$17.79M	-$11.62M
YoY Change	53.06%	-57.25%
NET CHANGE
Cash From Operating Activities	$5.042M	-$39.61M
Cash From Investing Activities	-$1.616M	-$227.0K
Cash From Financing Activities	-$17.79M	-$11.62M
Net Change In Cash	-$14.66M	-$52.96M
YoY Change	-72.32%	31.82%
FREE CASH FLOW
Cash From Operating Activities	$5.042M	-$39.61M
Capital Expenditures	$1.598M	$3.301M
Free Cash Flow	$3.444M	-$42.91M
YoY Change	-108.03%	124.04%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021Q1	dei	Amendment Flag AmendmentFlag	false
CY2021Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000913241
CY2021Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2021Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	9730000	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	8943000	USD
CY2020Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	9055000	USD
CY2021Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2020Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2020Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2020Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	245000000	shares
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	245000000	shares
CY2020Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	245000000	shares
CY2021Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	133513000	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	133247000	shares
CY2020Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	133159000	shares
CY2021Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	82728000	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	82616000	shares
CY2020Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	83046000	shares
CY2021Q1	dei	Entity Shell Company EntityShellCompany	false
CY2021Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	82756966	shares
CY2021Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	50785000	shares
CY2020Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	50631000	shares
CY2020Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	50113000	shares
CY2021Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	0	USD
CY2020Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	0	USD
CY2021Q1	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax	-252000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax	-489000	USD
CY2021Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.15
CY2020Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.15
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	0.339
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.376
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.005
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.016
CY2021Q1	dei	Document Type DocumentType	10-Q
CY2021Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2021Q1	dei	Document Period End Date DocumentPeriodEndDate	2021-03-31
CY2021Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2021Q1	dei	Entity File Number EntityFileNumber	0-23702
CY2021Q1	dei	Entity Registrant Name EntityRegistrantName	STEVEN MADDEN, LTD.
CY2021Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2021Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	13-3588231
CY2021Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	52-16 Barnett Avenue
CY2021Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Long Island City
CY2021Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2021Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	11104
CY2021Q1	dei	City Area Code CityAreaCode	718
CY2021Q1	dei	Local Phone Number LocalPhoneNumber	446-1800
CY2021Q1	dei	Security12b Title Security12bTitle	Common Stock, par value $.0001 per share
CY2021Q1	dei	Trading Symbol TradingSymbol	SHOO
CY2021Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2021Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2021Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2021Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	17415000	USD
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	233202000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	247864000	USD
CY2020Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	211138000	USD
CY2021Q1	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	39788000	USD
CY2020Q4	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	39302000	USD
CY2020Q1	us-gaap	Available For Sale Securities Current AvailableForSaleSecuritiesCurrent	34271000	USD
CY2021Q1	us-gaap	Accounts Receivable Net AccountsReceivableNet	34722000	USD
CY2020Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	25044000	USD
CY2020Q1	us-gaap	Accounts Receivable Net AccountsReceivableNet	30143000	USD
CY2021Q1	us-gaap	Receivables Net Current ReceivablesNetCurrent	285162000	USD
CY2020Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	252671000	USD
CY2020Q1	us-gaap	Receivables Net Current ReceivablesNetCurrent	231408000	USD
CY2021Q1	us-gaap	Inventory Net InventoryNet	106561000	USD
CY2020Q4	us-gaap	Inventory Net InventoryNet	101420000	USD
CY2020Q1	us-gaap	Inventory Net InventoryNet	102265000	USD
CY2021Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	16667000	USD
CY2020Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	24194000	USD
CY2021Q1	us-gaap	Prepaid Taxes PrepaidTaxes	18429000	USD
CY2020Q4	us-gaap	Prepaid Taxes PrepaidTaxes	14525000	USD
CY2020Q1	us-gaap	Prepaid Taxes PrepaidTaxes	7373000	USD
CY2021Q1	us-gaap	Assets Current AssetsCurrent	734531000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	698241000	USD
CY2020Q1	us-gaap	Assets Current AssetsCurrent	640792000	USD
CY2021Q1	us-gaap	Notes Receivable Related Parties Noncurrent NotesReceivableRelatedPartiesNoncurrent	1081000	USD
CY2020Q4	us-gaap	Notes Receivable Related Parties Noncurrent NotesReceivableRelatedPartiesNoncurrent	1180000	USD
CY2020Q1	us-gaap	Notes Receivable Related Parties Noncurrent NotesReceivableRelatedPartiesNoncurrent	1463000	USD
CY2021Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	40458000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	43268000	USD
CY2020Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	52206000	USD
CY2021Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	99510000	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	101379000	USD
CY2020Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	127187000	USD
CY2021Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	5216000	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	4822000	USD
CY2020Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2982000	USD
CY2021Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	5414000	USD
CY2020Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	5415000	USD
CY2020Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	6422000	USD
CY2021Q1	us-gaap	Goodwill Goodwill	167979000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	168265000	USD
CY2020Q1	us-gaap	Goodwill Goodwill	165855000	USD
CY2021Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	114754000	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	115191000	USD
CY2020Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	148997000	USD
CY2021Q1	us-gaap	Assets Assets	1168943000	USD
CY2020Q4	us-gaap	Assets Assets	1137761000	USD
CY2020Q1	us-gaap	Assets Assets	1145904000	USD
CY2021Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	99007000	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	73904000	USD
CY2020Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	76284000	USD
CY2021Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	120253000	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	118083000	USD
CY2020Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	87698000	USD
CY2020Q1	shoo	Advances From Factor Current AdvancesFromFactorCurrent	29100000	USD
CY2021Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	33359000	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	34257000	USD
CY2020Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	37517000	USD
CY2021Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	0	USD
CY2020Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	5799000	USD
CY2020Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	0	USD
CY2021Q1	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	113000	USD
CY2020Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	0	USD
CY2020Q1	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	0	USD
CY2021Q1	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	3761000	USD
CY2020Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	355684000	USD
CY2020Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	3873000	USD
CY2020Q1	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	2113000	USD
CY2021Q1	us-gaap	Liabilities Current LiabilitiesCurrent	256493000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	235916000	USD
CY2020Q1	us-gaap	Liabilities Current LiabilitiesCurrent	232712000	USD
CY2021Q1	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	564000	USD
CY2020Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	207000	USD
CY2020Q1	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	6440000	USD
CY2021Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	96246000	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	98592000	USD
CY2020Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	121187000	USD
CY2021Q1	us-gaap	Deferred Tax And Other Liabilities Noncurrent DeferredTaxAndOtherLiabilitiesNoncurrent	2767000	USD
CY2020Q4	us-gaap	Deferred Tax And Other Liabilities Noncurrent DeferredTaxAndOtherLiabilitiesNoncurrent	2562000	USD
CY2020Q1	us-gaap	Deferred Tax And Other Liabilities Noncurrent DeferredTaxAndOtherLiabilitiesNoncurrent	3961000	USD
CY2021Q1	us-gaap	Other Liabilities OtherLiabilities	12105000	USD
CY2020Q4	us-gaap	Other Liabilities OtherLiabilities	10115000	USD
CY2020Q1	us-gaap	Other Liabilities OtherLiabilities	7980000	USD
CY2021Q1	us-gaap	Liabilities Liabilities	368175000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	347392000	USD
CY2020Q1	us-gaap	Liabilities Liabilities	372280000	USD
CY2021Q1	us-gaap	Common Stock Value CommonStockValue	8000	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	8000	USD
CY2020Q1	us-gaap	Common Stock Value CommonStockValue	6000	USD
CY2021Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	485556000	USD
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	478463000	USD
CY2020Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	460777000	USD
CY2021Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	1288322000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	1279550000	USD
CY2020Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	1280496000	USD
CY2021Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-28529000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-29164000	USD
CY2020Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-45245000	USD
CY2021Q1	us-gaap	Treasury Stock Value TreasuryStockValue	957829000	USD
CY2020Q4	us-gaap	Treasury Stock Value TreasuryStockValue	952271000	USD
CY2020Q1	us-gaap	Treasury Stock Value TreasuryStockValue	934827000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	787528000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	776586000	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	761207000	USD
CY2021Q1	us-gaap	Minority Interest MinorityInterest	13240000	USD
CY2020Q4	us-gaap	Minority Interest MinorityInterest	13783000	USD
CY2020Q1	us-gaap	Minority Interest MinorityInterest	12417000	USD
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	800768000	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	790369000	USD
CY2020Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	773624000	USD
CY2021Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1168943000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1137761000	USD
CY2020Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1145904000	USD
CY2021Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	358901000	USD
CY2021Q1	us-gaap	Other Income OtherIncome	2124000	USD
CY2020Q1	us-gaap	Other Income OtherIncome	3484000	USD
CY2021Q1	us-gaap	Revenues Revenues	361025000	USD
CY2020Q1	us-gaap	Revenues Revenues	359168000	USD
CY2021Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	221921000	USD
CY2020Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	225704000	USD
CY2021Q1	us-gaap	Gross Profit GrossProfit	139104000	USD
CY2020Q1	us-gaap	Gross Profit GrossProfit	133464000	USD
CY2021Q1	us-gaap	Operating Expenses OperatingExpenses	110448000	USD
CY2020Q1	us-gaap	Operating Expenses OperatingExpenses	121373000	USD
CY2021Q1	shoo	Impairment Of Store Fixed Assets And Lease Right Of Use Assets ImpairmentOfStoreFixedAssetsAndLeaseRightOfUseAssets	612000	USD
CY2020Q1	shoo	Impairment Of Store Fixed Assets And Lease Right Of Use Assets ImpairmentOfStoreFixedAssetsAndLeaseRightOfUseAssets	28821000	USD
CY2020Q1	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	9518000	USD
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	28044000	USD
CY2020Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-26248000	USD
CY2021Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-37000	USD
CY2020Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	1046000	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	28007000	USD
CY2020Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-25202000	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	5676000	USD
CY2020Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-7401000	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	22331000	USD
CY2020Q1	us-gaap	Profit Loss ProfitLoss	-17801000	USD
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.27
CY2020Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.22
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.26
CY2020Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.22
CY2021Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	79038000	shares
CY2020Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	78875000	shares
CY2021Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	2851000	shares
CY2020Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2021Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	81889000	shares
CY2020Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	78875000	shares
CY2021Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.15
CY2020Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.15
CY2021Q1	us-gaap	Profit Loss ProfitLoss	22331000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax	-302000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	0	USD
CY2021Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-302000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Derivatives Qualifying As Hedges Before Tax Portion Attributable To Parent OtherComprehensiveIncomeDerivativesQualifyingAsHedgesBeforeTaxPortionAttributableToParent	875000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax	-252000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	623000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	573000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-252000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	321000	USD
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	22652000	USD
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	820000	USD
CY2021Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	21832000	USD
CY2020Q1	us-gaap	Profit Loss ProfitLoss	-17801000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax	-15650000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	0	USD
CY2020Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-15650000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Derivatives Qualifying As Hedges Before Tax Portion Attributable To Parent OtherComprehensiveIncomeDerivativesQualifyingAsHedgesBeforeTaxPortionAttributableToParent	1676000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodTax	-489000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	1187000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Before Tax OtherComprehensiveIncomeLossBeforeTax	-13974000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	-489000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-14463000	USD
CY2020Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-32264000	USD
CY2020Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-8000	USD
CY2020Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-32256000	USD
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	790369000	USD
CY2021Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	5558000	USD
CY2021Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1554000	USD
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	5539000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-302000	USD
CY2021Q1	us-gaap	Unrealized Gain Loss On Cash Flow Hedging Instruments UnrealizedGainLossOnCashFlowHedgingInstruments	623000	USD
CY2021Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	12425000	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	22331000	USD
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	800768000	USD
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	841224000	USD
CY2020Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	29139000	USD
CY2020Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	874000	USD
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	5686000	USD
CY2020Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-15650000	USD
CY2020Q1	us-gaap	Unrealized Gain Loss On Cash Flow Hedging Instruments UnrealizedGainLossOnCashFlowHedgingInstruments	1187000	USD
CY2020Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	12459000	USD
CY2020Q1	us-gaap	Business Combination Acquisition Of Less Than100 Percent Noncontrolling Interest Fair Value BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue	298000	USD
CY2020Q1	us-gaap	Profit Loss ProfitLoss	-17801000	USD
CY2020Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	773624000	USD
CY2021Q1	us-gaap	Profit Loss ProfitLoss	22331000	USD
CY2020Q1	us-gaap	Profit Loss ProfitLoss	-17801000	USD
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	5539000	USD
CY2020Q1	us-gaap	Share Based Compensation ShareBasedCompensation	5686000	USD
CY2021Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4028000	USD
CY2020Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4996000	USD
CY2021Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-222000	USD
CY2020Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-53000	USD
CY2020Q1	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	9518000	USD
CY2021Q1	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	612000	USD
CY2020Q1	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	28821000	USD
CY2021Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	206000	USD
CY2020Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-8338000	USD
CY2021Q1	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	6000	USD
CY2020Q1	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	8000	USD
CY2021Q1	us-gaap	Increase Decrease In Notes Receivable Related Parties IncreaseDecreaseInNotesReceivableRelatedParties	-102000	USD
CY2020Q1	us-gaap	Increase Decrease In Notes Receivable Related Parties IncreaseDecreaseInNotesReceivableRelatedParties	-102000	USD
CY2021Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	470000	USD
CY2020Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	USD
CY2021Q1	shoo	Recoverynetofprovisionforbaddebtexpenserelatedtocustomerbankruptcy Recoverynetofprovisionforbaddebtexpenserelatedtocustomerbankruptcy	919000	USD
CY2020Q1	shoo	Recoverynetofprovisionforbaddebtexpenserelatedtocustomerbankruptcy Recoverynetofprovisionforbaddebtexpenserelatedtocustomerbankruptcy	0	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	8759000	USD
CY2020Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-8023000	USD
CY2021Q1	shoo	Factor Accounts Receivable FactorAccountsReceivable	32491000	USD
CY2020Q1	shoo	Factor Accounts Receivable FactorAccountsReceivable	14937000	USD
CY2021Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	5141000	USD
CY2020Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-34631000	USD
CY2021Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3319000	USD
CY2020Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	8000000	USD
CY2021Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	22097000	USD
CY2020Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-71108000	USD
CY2021Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-112000	USD
CY2020Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-8821000	USD
CY2021Q1	shoo	Leases And Other Liabilities LeasesAndOtherLiabilities	182000	USD
CY2020Q1	shoo	Leases And Other Liabilities LeasesAndOtherLiabilities	-2426000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	5042000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-39609000	USD
CY2021Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1598000	USD
CY2020Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3301000	USD
CY2021Q1	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	2054000	USD
CY2020Q1	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	5542000	USD
CY2021Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	2036000	USD
CY2020Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	8616000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1616000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-227000	USD
CY2021Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1554000	USD
CY2020Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	874000	USD
CY2021Q1	us-gaap	Proceeds From Payments To Minority Shareholders ProceedsFromPaymentsToMinorityShareholders	-1363000	USD
CY2020Q1	us-gaap	Proceeds From Payments To Minority Shareholders ProceedsFromPaymentsToMinorityShareholders	0	USD
CY2021Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	5558000	USD
CY2020Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	29139000	USD
CY2021Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	12425000	USD
CY2020Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	12459000	USD
CY2021Q1	us-gaap	Line Of Credit Assumed1 LineOfCreditAssumed1	0	USD
CY2020Q1	us-gaap	Line Of Credit Assumed1 LineOfCreditAssumed1	42539000	USD
CY2021Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	0	USD
CY2020Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	13439000	USD
CY2021Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-17792000	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-11624000	USD
CY2021Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-296000	USD
CY2020Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-1503000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-14662000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-52963000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	247864000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	264101000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	233202000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	211138000	USD
CY2021Q1	us-gaap	Basis Of Accounting BasisOfAccounting	<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note A – Basis of Reporting</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed consolidated financial statements of Steven Madden, Ltd. and subsidiaries (the “Company”) have been prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”) for interim financial information and pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, such statements include all adjustments (consisting only of normal recurring items) that are considered necessary for a fair presentation of the financial position of the Company and the results of its operations and cash flows for the periods presented. Certain reclassifications were made to prior years' presentation to conform to the 2021 presentation. The results of operations for the three-month period ended March 31, 2021 are not necessarily indicative of the operating results for the full year. These financial statements should be read in conjunction with the financial statements and related disclosures for the year ended December 31, 2020 included in the Annual Report of Steven Madden, Ltd. on Form 10-K filed with the SEC on March 16, 2021.</span></div>
CY2021Q1	shoo	Salary Reduction Percentage For Executives SalaryReductionPercentageForExecutives	0.30
CY2021Q1	shoo	Salary Reduction For Non Executive Employees SalaryReductionForNonExecutiveEmployees	100000	USD
CY2020	us-gaap	Restructuring Costs RestructuringCosts	7181000	USD
CY2021Q1	us-gaap	Restructuring Costs RestructuringCosts	806000	USD
CY2021Q1	us-gaap	Reclassifications Reclassifications	Note C – ReclassificationCertain reclassifications were made to prior years' amounts to conform to the 2021 presentation, primarily as it relates to segment reporting of corporate expenses and corporate assets. See Note Q - Operating Segment Information, for more information.
CY2021Q1	us-gaap	Use Of Estimates UseOfEstimates	Significant areas involving management estimates include variable consideration included in revenue, allowances for bad debts, inventory valuation, valuation of intangible assets, impairment of long-lived assets, litigation reserves and contingent payment liabilities. The Company estimates variable consideration for future customer chargebacks and markdown allowances, discounts, returns and other miscellaneous compliance-related deductions that relate to the current-period sales. The Company evaluates anticipated chargebacks by reviewing several performance indicators of its major customers. These performance indicators, which include retailers’ inventory levels, sell-through rates and gross margin levels, are analyzed by management to estimate the amount of the anticipated customer allowance.
CY2021Q1	shoo	Factoring Fee FactoringFee	0.0020
CY2021Q1	shoo	Termination Notice In Days TerminationNoticeInDays	60	USD
CY2021Q1	us-gaap	Foreign Currency Contract Asset Fair Value Disclosure ForeignCurrencyContractAssetFairValueDisclosure	270000	USD
CY2021Q1	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	270000	USD
CY2021Q1	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	677000	USD
CY2021Q1	us-gaap	Foreign Currency Contracts Liability Fair Value Disclosure ForeignCurrencyContractsLiabilityFairValueDisclosure	439000	USD
CY2021Q1	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	1116000	USD
CY2020Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	207000	USD
CY2020Q4	us-gaap	Foreign Currency Contracts Liability Fair Value Disclosure ForeignCurrencyContractsLiabilityFairValueDisclosure	997000	USD
CY2020Q4	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	1204000	USD
CY2020Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	207000	USD
CY2021Q1	shoo	Business Acquisition Contingent Consideration Changein Estimate BusinessAcquisitionContingentConsiderationChangeinEstimate	470000	USD
CY2021Q1	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	677000	USD
CY2019Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	9124000	USD
CY2020Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	207000	USD
CY2021Q1	shoo	Total Consideration Liability TotalConsiderationLiability	677000	USD
CY2021Q1	shoo	Total Consideration Liability Current TotalConsiderationLiabilityCurrent	113000	USD
CY2021Q1	shoo	Total Consideration Liability Non Current TotalConsiderationLiabilityNonCurrent	564000	USD
CY2021Q1	shoo	Lease Modification Expense LeaseModificationExpense	6570000	USD
CY2021Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	99510000	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	101379000	USD
CY2021Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	33359000	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	34257000	USD
CY2021Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	96246000	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	98592000	USD
CY2021Q1	shoo	Lease Liability LeaseLiability	129605000	USD
CY2020Q4	shoo	Lease Liability LeaseLiability	132849000	USD
CY2021Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y
CY2020Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y
CY2021Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.042
CY2020Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.043
CY2020Q3	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	433000	USD
CY2020Q1	us-gaap	Impairment Of Leasehold ImpairmentOfLeasehold	22183000	USD
CY2021Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	10192000	USD
CY2020Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	11383000	USD
CY2021Q1	us-gaap	Variable Lease Cost VariableLeaseCost	7343000	USD
CY2020Q1	us-gaap	Variable Lease Cost VariableLeaseCost	43000	USD
CY2021Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	0	USD
CY2020Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	13000	USD
CY2021Q1	us-gaap	Sublease Income SubleaseIncome	80000	USD
CY2020Q1	us-gaap	Sublease Income SubleaseIncome	201000	USD
CY2021Q1	us-gaap	Lease Cost LeaseCost	17455000	USD
CY2020Q1	us-gaap	Lease Cost LeaseCost	11238000	USD
CY2021Q1	shoo	Lease Modification Expense LeaseModificationExpense	6570000	USD
CY2021Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	10901000	USD
CY2020Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	11545000	USD
CY2021Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	7283000	USD
CY2020Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	USD
CY2021Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	8770000	USD
CY2020Q1	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	10333000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	30199000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	32274000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	23792000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	18740000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	15345000	USD
CY2021Q1	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	35.87
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	23398000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	143748000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	14143000	USD
CY2021Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	129605000	USD
CY2020Q3	us-gaap	Asset Impairment Charges AssetImpairmentCharges	28821000	USD
CY2020Q1	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	612000	USD
CY2019Q2	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	200000000	USD
CY2021Q1	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	1940000	USD
CY2021Q1	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	109650000	USD
CY2021Q1	us-gaap	Shares Paid For Tax Withholding For Share Based Compensation SharesPaidForTaxWithholdingForShareBasedCompensation	100853	shares
CY2021Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	3618000	USD
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	3593000	shares
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	4565000	shares
CY2021Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2769000	shares
CY2020Q1	shoo	Maximum Number Of Potential Dilutive Shares Issued Upon Vesting MaximumNumberOfPotentialDilutiveSharesIssuedUponVesting	17000	USD
CY2021Q1	shoo	Maximum Number Of Potential Dilutive Shares Issued Upon Vesting MaximumNumberOfPotentialDilutiveSharesIssuedUponVesting	300000	USD
CY2021Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	28007000	USD
CY2020Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-25202000	USD
CY2021Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	5676000	USD
CY2020Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-7401000	USD
CY2021Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.203
CY2020Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.294
CY2019Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	11000000	shares
CY2021Q1	us-gaap	Stock Issued During Period Shares Share Based Compensation StockIssuedDuringPeriodSharesShareBasedCompensation	2668950	shares
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	8331050	shares
CY2021Q1	shoo	Share Based Payment Vested Awards ShareBasedPaymentVestedAwards	2092188	shares
CY2021Q1	shoo	Share Based Payment Unvested Awards ShareBasedPaymentUnvestedAwards	3008209	shares
CY2021Q1	us-gaap	Share Based Compensation ShareBasedCompensation	5539000	USD
CY2020Q1	us-gaap	Share Based Compensation ShareBasedCompensation	5686000	USD
CY2020Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	225000	shares
CY2020Q4	us-gaap	Share Price SharePrice	24.83
CY2021Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1554000	USD
CY2020Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	874000	USD
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	867000	USD
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	737000	USD
CY2021Q1	shoo	Share Based Compensation Arrangement By Share Based Payment Award Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriod	356603	shares
CY2021Q1	shoo	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable During Period Weighted Average Exercise Price In Dollars Per Share ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableDuringPeriodWeightedAverageExercisePriceInDollarsPerShare	25.55
CY2020Q1	shoo	Share Based Compensation Arrangement By Share Based Payment Award Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriod	388479	shares
CY2020Q1	shoo	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable During Period Weighted Average Exercise Price In Dollars Per Share ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableDuringPeriodWeightedAverageExercisePriceInDollarsPerShare	26.04
CY2021Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	400713	shares
CY2021Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y2M12D
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	0.484
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.2
CY2021Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P3Y
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.018
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.015
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	10.33
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	10.22
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2674000	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	26.80
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	11000	shares
CY2021Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	33.60
CY2021Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	65000	shares
CY2021Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	23.92
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	0	shares
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	0
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2620000	shares
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	26.90
CY2021Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	0	USD
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	2219000	shares
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	26.76
CY2021Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P2Y10M24D
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	0	USD
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	3651000	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	20.81
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	4427000	shares
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	19.84
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	187000	shares
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	38.10
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	366000	shares
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	34.69
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	223000	shares
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	28.50
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	219000	shares
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	27.15
CY2021Q1	us-gaap	Stock Issued During Period Shares Restricted Stock Award Forfeited StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited	22000	shares
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	35.82
CY2020Q1	us-gaap	Stock Issued During Period Shares Restricted Stock Award Forfeited StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited	9000	shares
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	32.84
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	3593000	shares
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	21.14
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	4565000	shares
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	20.66
CY2021Q1	shoo	Employee Service Share Based Compensation Nonvested Restricted Awards Total Compensation Cost Not Yet Recognized Period For Recognition EmployeeServiceShareBasedCompensationNonvestedRestrictedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition	P4Y2M12D
CY2020Q4	us-gaap	Goodwill Goodwill	168265000	USD
CY2021Q1	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-286000	USD
CY2021Q1	us-gaap	Goodwill Goodwill	167979000	USD
CY2021Q1	us-gaap	Finite Lived Trade Names Gross FiniteLivedTradeNamesGross	9025000	USD
CY2021Q1	us-gaap	Finite Lived Customer Lists Gross FiniteLivedCustomerListsGross	38680000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	47705000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	30391000	USD
CY2021Q1	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	-1490000	USD
CY2021Q1	shoo	Finite Lived Intangible Assets Net Of Amortization FiniteLivedIntangibleAssetsNetOfAmortization	15824000	USD
CY2021Q1	us-gaap	Indefinite Lived Contractual Rights IndefiniteLivedContractualRights	27726000	USD
CY2021Q1	us-gaap	Indefinite Lived Trademarks IndefiniteLivedTrademarks	71204000	USD
CY2021Q1	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	153858000	USD
CY2021Q1	shoo	Accumulated Amortization AccumulatedAmortization	30391000	USD
CY2021Q1	us-gaap	Impairment Of Intangible Assets Indefinitelived Excluding Goodwill ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill	-8713000	USD
CY2021Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	114754000	USD
CY2021Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	831000	USD
CY2020Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	891000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	1646000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	1735000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	1735000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	1735000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	1735000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	7238000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	15824000	USD
CY2021Q1	us-gaap	Derivative Notional Amount DerivativeNotionalAmount	36955	USD
CY2021Q1	us-gaap	Foreign Currency Contract Asset Fair Value Disclosure ForeignCurrencyContractAssetFairValueDisclosure	270000	USD
CY2021Q1	us-gaap	Foreign Currency Contracts Liability Fair Value Disclosure ForeignCurrencyContractsLiabilityFairValueDisclosure	439000	USD
CY2020Q1	us-gaap	Derivative Net Hedge Ineffectiveness Gain Loss DerivativeNetHedgeIneffectivenessGainLoss	176000	USD
CY2021Q1	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax	-169000	USD
CY2021Q1	us-gaap	Derivative Instruments Gain Loss Reclassified From Accumulated Oci Into Income Effective Portion Net DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet	0	USD
CY2020Q1	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax	1178000	USD
CY2020Q1	us-gaap	Derivative Instruments Gain Loss Reclassified From Accumulated Oci Into Income Effective Portion Net DerivativeInstrumentsGainLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortionNet	176000	USD
CY2021Q1	us-gaap	Other Commitment OtherCommitment	18363000	USD
CY2021Q1	us-gaap	Revenues Revenues	361025000	USD
CY2021Q1	us-gaap	Gross Profit GrossProfit	139104000	USD
CY2021Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	28044000	USD
CY2021Q1	us-gaap	Assets Assets	1168943000	USD
CY2021Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1598000	USD
CY2020Q1	us-gaap	Revenues Revenues	359168000	USD
CY2020Q1	us-gaap	Gross Profit GrossProfit	133464000	USD
CY2020Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-26248000	USD
CY2020Q1	us-gaap	Assets Assets	1145904000	USD
CY2020Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3301000	USD
CY2021Q1	us-gaap	Revenues Revenues	361025000	USD
CY2020Q1	us-gaap	Revenues Revenues	359168000	USD
CY2021Q1	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	150000000	USD
CY2021Q1	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	150000000	USD
CY2021Q1	shoo	Maximum Increase Of Availability Of Credit MaximumIncreaseOfAvailabilityOfCredit	100000000	USD
CY2021Q1	us-gaap	Debt Instrument Basis Spread On Variable Rate1 DebtInstrumentBasisSpreadOnVariableRate1	0.0050
CY2021Q1	us-gaap	Line Of Credit Facility Commitment Fee Percentage LineOfCreditFacilityCommitmentFeePercentage	0.0040
CY2021Q1	shoo	Line Cap Dollar Amount Before Base Trigger LineCapDollarAmountBeforeBaseTrigger	22500000	USD
CY2021Q1	shoo	Line Cap Percentage Before Base Trigger LineCapPercentageBeforeBaseTrigger	0.15	USD
CY2021Q1	shoo	Line Cap Dollar Amount After Base Trigger LineCapDollarAmountAfterBaseTrigger	15000000	USD
CY2021Q1	shoo	Line Cap Percentage After Base Trigger LineCapPercentageAfterBaseTrigger	0.10	USD

Files In Submission

Name	View Source	Status
0001628280-21-009267-index-headers.html	Edgar Link	pending
0001628280-21-009267-index.html	Edgar Link	pending
0001628280-21-009267.txt	Edgar Link	pending
0001628280-21-009267-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
shoo-20210331.htm	Edgar Link	pending
shoo-20210331.xsd	Edgar Link	pending
shoo-20210331_cal.xml	Edgar Link	unprocessable
shoo-20210331_def.xml	Edgar Link	unprocessable
shoo-20210331_htm.xml	Edgar Link	completed
shoo-20210331_lab.xml	Edgar Link	unprocessable
shoo-20210331_pre.xml	Edgar Link	unprocessable
shoo-ex311x20210331.htm	Edgar Link	pending
shoo-ex312x20210331.htm	Edgar Link	pending
shoo-ex321x20210331.htm	Edgar Link	pending
shoo-ex322x20210331.htm	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SHOO
STEVEN MADDEN, LTD. Stock $shoo

2021 Q1 Form 10-Q Financial Statement

#000162828021009267 Filed on May 06, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SHOO STEVEN MADDEN, LTD. Stock $shoo

2021 Q1 Form 10-Q Financial Statement

#000162828021009267 Filed on May 06, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SHOO
STEVEN MADDEN, LTD. Stock $shoo